Boston (1)

Bladder Cancer (1)

Metastatic Urothelial Carcinoma (1)

Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter (1)

Urothelial Cancer (1)

Recruiting (1)

phase 1 (1)

Dana-Farber Cancer Institute (1)

Gilead Sciences (1)

enfortumab vedotin-ejfv (ev) (1)

sacituzumab govitecan (sg) (1)

drug (1)

Other (1)

Interventional (1)

metastatic urothelial carcinoma of the renal pelvis and ureter

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Sep 28, 2022